Cargando…

Topical retapamulin in the management of infected traumatic skin lesions

Retapamulin is a novel semisynthetic pleuromutilin antibiotic specifically designed for use as a topical agent. The unique mode of action by which retapamulin selectively inhibits bacterial protein synthesis differentiates it from other nonpleuromutilin antibacterial agents that target the ribosome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shawar, Ribhi, Scangarella-Oman, Nicole, Dalessandro, MaryBeth, Breton, John, Twynholm, Monique, Li, Gang, Garges, Harmony
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697516/ https://www.ncbi.nlm.nih.gov/pubmed/19436611

Ejemplares similares

Clinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections()
por: Bohaty, Benjamin R., et al.
Publicado: (2015)

In Vitro Antimicrobial Activities of Fusidic Acid and Retapamulin against Mupirocin- and Methicillin-Resistant Staphylococcus aureus
por: Park, Sang Hyun, et al.
Publicado: (2015)

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance
por: Chen, Wenjing, et al.
Publicado: (2020)

Strengthening accountability of the global health metrics enterprise
por: Shiffman, Jeremy, et al.
Publicado: (2020)

Generating Global Priority for Addressing Rheumatic Heart Disease: A Qualitative Policy Analysis
por: Shawar, Yusra Ribhi, et al.
Publicado: (2020)

Political challenges to prioritizing gender in global health organisations
por: Shawar, Yusra Ribhi, et al.
Publicado: (2020)

A global priority: addressing violence against children
por: Shawar, Yusra Ribhi, et al.
Publicado: (2021)

Global priority for the care of orphans and other vulnerable children: transcending problem definition challenges
por: Shawar, Yusra Ribhi, et al.
Publicado: (2023)

Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
por: O'Riordan, William, et al.
Publicado: (2017)

Corrigendum: Generating global political priority for urban health: the role of the urban health epistemic community
por: Shawar, Yusra Ribhi, et al.
Publicado: (2017)

Generating global political priority for urban health: the role of the urban health epistemic community
por: Shawar, Yusra Ribhi, et al.
Publicado: (2017)

Managing Differences Among Pro-nutrition Actors on Corporate Engagement; A Response to the Recent Commentary
por: Fanzo, Jessica, et al.
Publicado: (2022)

In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium
por: Jensen, Jørgen Skov, et al.
Publicado: (2020)

714. Analysis of the Effect of Urine on the In Vitro Activity of Gepotidacin and Levofloxacin Against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus
por: Koeth, Laura M, et al.
Publicado: (2019)

724. The In Vitro Activity of Gepotidacin and Comparator Agents Against Anaerobic Bacterial Isolates
por: Hackel, Meredith, et al.
Publicado: (2019)

International norms and the politics of sexuality education in Nigeria
por: Shiffman, Jeremy, et al.
Publicado: (2018)

Power dynamics and health initiative design as determinants of peacebuilding: a case study of the Syrian conflict
por: AlGhatrif, Majd, et al.
Publicado: (2022)

1218. Retapamulin as a Potential Decolonizing Agent: Activity against Mupirocin-Resistant Strains From Pediatric Patients With Methicillin-Resistant Staphylococcus aureus Infection
por: Patel, Ami, et al.
Publicado: (2018)

The rise and fall of global health issues: an arenas model applied to the COVID-19 pandemic shock
por: Smith, Stephanie L., et al.
Publicado: (2021)

Challenges to Establish Effective Public-Private Partnerships to Address Malnutrition in All Its Forms
por: Fanzo, Jessica, et al.
Publicado: (2021)

Understanding resilience, self-reliance and increasing country voice: a clash of ideologies in global health
por: Shawar, Yusra Ribhi, et al.
Publicado: (2023)

Why ‘elevating country voice’ is not decolonizing global health: A frame analysis of in-depth interviews
por: Kunnuji, Michael, et al.
Publicado: (2023)

An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information
por: Hong, Woosung, et al.
Publicado: (2018)

568. A Randomized, Double-Blinded, Placebo-Controlled Trial of Retapamulin for Nasal and Rectal Decolonization of Mupirocin-Resistant Methicillin-Resistant Staphylococcus aureus Among Children
por: Patel, Ami, et al.
Publicado: (2019)

1249. Genetic Evidence That Gepotidacin Shows Well-balanced Dual Targeting against DNA Gyrase And Topoisomerase IV in Neisseria gonorrhoeae
por: Chan, Pan, et al.
Publicado: (2020)

1262. Antimicrobial Activity of Gepotidacin against Clinical Isolates of Escherichia coli and Staphylococcus saprophyticus Collected Worldwide in 2019
por: Arends, S J Ryan, et al.
Publicado: (2020)

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)
por: Arends, S. J. Ryan, et al.
Publicado: (2023)

Factors shaping the global political priority of addressing elder abuse: a qualitative policy analysis
por: Mikton, Christopher, et al.
Publicado: (2022)

Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer
por: Green, Adele C., et al.
Publicado: (2020)

2159. Analysis of Resistance to Oral Standard-of-Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected in the United States in 2022
por: Arends, S J Ryan, et al.
Publicado: (2023)

Clinical resource allocation for the mitigation of elder abuse – Authors' reply
por: Shawar, Yusra Ribhi, et al.
Publicado: (2022)

1698. Trends in antimicrobial resistance among outpatient urine E. coli isolates in US females ≥12 years of age: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

1699. Variation of antimicrobial resistance by age groups for outpatient UTI isolates in US females: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management
por: Kaye, Keith S, et al.
Publicado: (2021)

Hyaluronic acid conjugates for topical treatment of skin cancer lesions
por: Krishnan, Vinu, et al.
Publicado: (2021)

In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes
por: Hackel, Meredith A., et al.
Publicado: (2022)

1062. Analysis of Resistance to Oral Standard of Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected Worldwide between 2019-2020
por: Arends, S J Ryan, et al.
Publicado: (2021)

Global health policy in the 21st century: Challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions
por: Briggs, Andrew M., et al.
Publicado: (2020)

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review
por: Stapleton, Ann E., et al.
Publicado: (2020)

Vitreoscilla filiformis Extract for Topical Skin Care: A Review
por: Gueniche, Audrey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ft2qo83eg4s6nani1q3hov0osp